G01N 2333/4753
Hepatocyte growth factor
Official title: Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
G01N2333/4753 (Hepatocyte growth factor) appears on 33 US grants and 97 published applications in this corpus.
Search patents in G01N- Granted patents
- 33
- Published applications
- 97
- Assignees
- 50
- Inventors
- 170
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 5 |
| 2006 | 0 | 4 |
| 2007 | 1 | 5 |
| 2008 | 2 | 4 |
| 2009 | 3 | 5 |
| 2010 | 2 | 7 |
| 2011 | 1 | 3 |
| 2012 | 0 | 9 |
| 2013 | 1 | 5 |
| 2014 | 2 | 3 |
| 2015 | 4 | 4 |
| 2016 | 3 | 2 |
| 2017 | 1 | 9 |
| 2018 | 0 | 1 |
| 2019 | 1 | 4 |
| 2020 | 2 | 4 |
| 2021 | 0 | 8 |
| 2022 | 1 | 2 |
| 2023 | 2 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Diagnostics of periodontitis14 Apr 2026US 12,601,745 B2Koninklijke Philips N. V.
- Method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population21 Oct 2025US 12,449,413 B2Cellresearch Corporation Pte. Ltd.
- Classification of periodontitis patients8 Oct 2024US 12,111,323 B2Koninklijke Philips N. V.
- Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness5 Dec 2023US 11,834,682 B2National Taiwan University
- Diagnostics of periodontitis based on salivary HGF and MMP-826 Sep 2023US 11,768,207 B2Koninklijke Philips N. V.
- Methods for monitoring molecular biomarkers for aging and disease27 Aug 2026US 2026/0251662 A9The Board of Trustees of the Leland Stanford Junior University
- Method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population2 Jul 2026US 2026/0185978 A1Cellresearch Corporation Pte. Ltd.
- Molecular marker for diagnosis, prognosis evaluation, and treatment of cardiac fibrosis14 May 2026US 2026/0133207 A1Central China Subcenter of National Center for Cardiovascular Diseases
- Methods for monitoring molecular biomarkers for aging and disease13 Nov 2025US 2025/0347701 A1The Board of Trustees of the Leland Stanford Junior University
- Tonsilar organoid preparation method and use thereof19 Jun 2025US 2025/0197812 A1
Most cited
By later US patents
- Monoclonal antibodies to hepatocyte growth factor32US 7,220,410 B2Galaxy Biotech, LLC · 2007
- Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met23US 6,344,321 B12002
- c-MET kinase binding proteins16US 7,803,907 B2Amgen Mountain View Inc. · 2010
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure15US 8,993,250 B2Astute Medical, Inc. · 2015
- Monoclonal antibodies to hepatocyte growth factor14US 7,494,650 B2Galaxy Biotech, LLC · 2009